Published in N Engl J Med on November 29, 1990
Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study (ICE-CHIP) | NCT00281073
Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) | NCT00000517
Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol (2009) 3.40
Benefits and risks of anticoagulation resumption following traumatic brain injury. JAMA Intern Med (2014) 2.10
Rates of hemorrhage during warfarin therapy for atrial fibrillation. CMAJ (2012) 1.68
Creating a Canadian stroke system. CMAJ (2001) 1.50
Atrial fibrillation--risk marker for stroke. N Engl J Med (1990) 1.46
Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence (2010) 1.26
Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis. PLoS One (2012) 1.24
Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med (2000) 1.08
Prevalence of transthoracic echocardiographic abnormalities in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Arch Med Sci (2010) 1.07
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Eur Heart J (2013) 1.03
Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial. CMAJ (2007) 1.03
The cost-effectiveness of different management strategies for patients on chronic warfarin therapy. J Gen Intern Med (2000) 1.02
Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation. J Gen Intern Med (2008) 1.01
Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. J Gen Intern Med (2005) 0.99
Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis. PLoS One (2012) 0.96
The predictive value of left atrial size for incident ischemic stroke and all-cause mortality in African Americans: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke (2008) 0.94
Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc (2009) 0.93
Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010. J Am Heart Assoc (2014) 0.92
Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa). Eur Heart J (2013) 0.92
Rapid access arrhythmia clinic for the diagnosis and management of new arrhythmias presenting in the community: a prospective, descriptive study. Heart (2004) 0.91
Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-making. Ther Adv Drug Saf (2014) 0.89
Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin. Int J Nephrol Renovasc Dis (2009) 0.89
Dabigatran in atrial fibrillation: pharmacology and clinical trials. J Interv Card Electrophysiol (2011) 0.87
Role of oral anticoagulation in management of atrial fibrillation. Heart (2004) 0.87
Stroke prevention in atrial fibrillation: concepts and controversies. Curr Cardiol Rev (2012) 0.86
Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol (2004) 0.86
The business case for quality improvement: oral anticoagulation for atrial fibrillation. Circ Cardiovasc Qual Outcomes (2011) 0.86
Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices. Vasc Health Risk Manag (2012) 0.85
Prevention of cardioembolic stroke. Neurotherapeutics (2011) 0.85
Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital. Heart (2004) 0.85
Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis. J Am Heart Assoc (2016) 0.83
Heart failure in thyrotoxicosis, an approach to management. Br J Clin Pharmacol (1998) 0.83
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation. Europace (2016) 0.83
Advancement in antithrombotics for stroke prevention in atrial fibrillation. J Interv Card Electrophysiol (2008) 0.83
High-risk antimicrobial prescriptions among ambulatory patients on warfarin. J Clin Pharm Ther (2011) 0.82
Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillation. Am J Cardiol (2011) 0.82
Stroke Prevention in Atrial Fibrillation: Where are We Now? Clin Med Insights Cardiol (2012) 0.82
Impact of dronedarone in atrial fibrillation and flutter on stroke reduction. Clin Interv Aging (2010) 0.81
Relationship between left atrial size and stroke in patients with sinus rhythm and preserved systolic function. Korean J Intern Med (2009) 0.81
Optimal loading dose for the initiation of warfarin: a systematic review. BMC Cardiovasc Disord (2010) 0.81
Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study. Thromb J (2005) 0.81
Fortnightly review: anticoagulation in heart disease. BMJ (1999) 0.81
The impact of warfarin use on clinical outcomes in atrial fibrillation: a population-based study. Can J Cardiol (2007) 0.80
Pharmacological management of atrial fibrillation: one, none, one hundred thousand. Cardiol Res Pract (2011) 0.80
Genetic epidemiology of intracerebral hemorrhage. J Stroke Cerebrovasc Dis (2007) 0.80
Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation: A Meta-Analysis of Observational Studies. Medicine (Baltimore) (2015) 0.80
Hemostasis and alterations of the central nervous system. Semin Thromb Hemost (2013) 0.79
Novel anticoagulants in atrial fibrillation stroke prevention. Ther Adv Chronic Dis (2012) 0.79
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy. Intern Emerg Med (2007) 0.79
Prevalence of oral anticoagulation in atrial fibrillation. Clinics (Sao Paulo) (2014) 0.78
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med (1991) 0.78
Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants. PLoS One (2014) 0.77
Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study. J Stroke Cerebrovasc Dis (2013) 0.77
Plasminogen activators and ischemic stroke: conditions for acute delivery. Semin Thromb Hemost (2013) 0.77
How well does the target INR level maintain in warfarin-treated patients with non-valvular atrial fibrillation? Yonsei Med J (2009) 0.76
Bleeding Complications to Long-Term Oral Anticoagulant Therapy. J Thromb Thrombolysis (1994) 0.76
Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulant Therapy Study (AFASAK 2): Methods and Design. J Thromb Thrombolysis (1995) 0.76
Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans. Am J Med (2014) 0.76
Physician compliance with outpatient oral anticoagulant guidelines in Auvergne, France. J Gen Intern Med (2003) 0.75
Poor adherence to anticoagulation guidelines in patients with non-valvular atrial fibrillation treated in a tertiary cardiology unit. Heart Asia (2015) 0.75
Atrial fibrillation in women: treatment. Nat Rev Cardiol (2016) 0.75
Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). J Arrhythm (2016) 0.75
Exploratory Network Meta Regression Analysis of Stroke Prevention in Atrial Fibrillation Fails to Identify Any Interactions with Treatment Effect. PLoS One (2016) 0.75
Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants. J Blood Med (2012) 0.75
LOWERING THE RISK FOR THROMBUS AND STROKE IN ATRIAL FIBRILLATION PATIENTS: Will Dabigatran Replace Warfarin? Clin Med Rev Vasc Health (2013) 0.75
Bleeding events associated with a low dose (110 mg) versus a high dose (150 mg) of dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis. BMC Cardiovasc Disord (2017) 0.75
Demonstration of anticoagulation patient self-testing feasibility at an Indian Health Service facility: A case series analysis. Pharm Pract (Granada) (2013) 0.75
Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort. Front Pharmacol (2017) 0.75
Atrial fibrillation. J Biomed Res (2013) 0.75
Evolution of left atrial thrombus with anticoagulant therapy-follow-up by transesophageal echocardiography. Korean J Intern Med (1995) 0.75
Anticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatran. Curr Control Trials Cardiovasc Med (2004) 0.75
How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation? Am J Cardiol (2016) 0.75
Managing atrial fibrillation in elderly people. What should target international normalised ratio be? BMJ (1999) 0.75
Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice. Postgrad Med J (2013) 0.75
Achieving target international normalization ratio in haemodialysis patients with atrial fibrillation: is it feasible? NDT Plus (2011) 0.75
Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons. PLoS One (2014) 0.75
Stroke Prevention in Atrial Fibrillation. J Atr Fibrillation (2010) 0.75
Evidence-based study on antithrombotic therapy in patients at risk of a stroke with paroxysmal atrial fibrillation. Exp Ther Med (2013) 0.75
[Antithrombotic therapy in atrial fibrillation: when vitamin K antagonists? When aspirin? When heparin? When combinations of anticoagulant and antiplatelet drugs?]. Herzschrittmacherther Elektrophysiol (2009) 0.75
Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial. Trials (2017) 0.75
Stroke prevention in atrial fibrillation: established oral anticoagulants versus novel anticoagulants-translating clinical trial data into practice. J Interv Card Electrophysiol (2014) 0.75
Antiplatelet therapy in the prevention of stroke. Drugs (1991) 0.75
[Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference]. Herzschrittmacherther Elektrophysiol (2007) 0.75
Anti-thrombotic strategies for patients with atrial fibrillation and heart failure. Heart Fail Rev (2002) 0.75
Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials? J Interv Card Electrophysiol (2004) 0.75
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77
Extended work shifts and the risk of motor vehicle crashes among interns. N Engl J Med (2005) 8.73
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med (2003) 6.70
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol (2011) 5.06
Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25
Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21
Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA (2003) 4.13
Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol (2005) 4.04
Comparison of risk factors for colon and rectal cancer. Int J Cancer (2004) 4.03
Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke (2009) 3.89
Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med (2002) 3.78
Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA Intern Med (2013) 3.67
Long-term outcomes of surgical and nonsurgical management of lumbar spinal stenosis: 8 to 10 year results from the maine lumbar spine study. Spine (Phila Pa 1976) (2005) 3.67
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care (2003) 3.57
Relation between dieting and weight change among preadolescents and adolescents. Pediatrics (2003) 3.36
Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study. Stroke (2007) 3.36
Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA (2007) 3.34
Extended work duration and the risk of self-reported percutaneous injuries in interns. JAMA (2006) 3.26
Impact of extended-duration shifts on medical errors, adverse events, and attentional failures. PLoS Med (2006) 3.22
Long-term outcomes of surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: 10 year results from the maine lumbar spine study. Spine (Phila Pa 1976) (2005) 3.17
Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science (2014) 3.14
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 3.12
Adult weight change and risk of postmenopausal breast cancer. JAMA (2006) 3.11
Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med (2002) 3.06
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med (2004) 3.06
Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol (2005) 3.02
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA (2002) 2.94
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol (2008) 2.93
Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci (2008) 2.91
CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology (2008) 2.90
Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol (2010) 2.78
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr (2003) 2.68
Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med (2005) 2.66
The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol (2009) 2.59
Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol (2003) 2.50
The unmet health care needs of homeless adults: a national study. Am J Public Health (2010) 2.36
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J (2011) 2.31
Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol (2013) 2.29
Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16 587 US men. Am J Clin Nutr (2003) 2.29
Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke (2003) 2.28
ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol (2012) 2.23
Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol (2006) 2.21
Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol (2003) 2.20
Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med (2002) 2.19
Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation (2009) 2.18
Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 2.17
Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med (2007) 2.16
Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med (2010) 2.15
Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev (2004) 2.10
Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol (2005) 2.08
Lung cancer in railroad workers exposed to diesel exhaust. Environ Health Perspect (2004) 2.06
Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med (2004) 2.06
Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care (2003) 2.00
Association of Fecundity With Changes in Adult Female Weight. Obstet Gynecol (2015) 1.97
Healthful dietary patterns and type 2 diabetes mellitus risk among women with a history of gestational diabetes mellitus. Arch Intern Med (2012) 1.92
National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med (2004) 1.92
Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med (2004) 1.91
Functional impact of breast cancer by age at diagnosis. J Clin Oncol (2004) 1.91
Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine. Am J Med (2004) 1.87
Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci (2009) 1.86
Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85
A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes Care (2004) 1.85
Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol (2011) 1.85
Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr (2012) 1.84
Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. Ophthalmology (2011) 1.81
Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events. Stroke (2009) 1.81
The validity of self-reported weight change among adolescents and young adults. Obesity (Silver Spring) (2007) 1.81
Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol (2004) 1.80
Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke (2002) 1.80
Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med (2002) 1.78
Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res (2005) 1.77
A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer (2007) 1.76
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst (2011) 1.75
NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr (2010) 1.74
Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med (2006) 1.74
Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer. Ann Intern Med (2002) 1.73
Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol (2004) 1.71
Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res (2004) 1.67
Protecting an endangered species: training physicians to conduct clinical research. Acad Med (2009) 1.66
Job stress and breast cancer risk: the nurses' health study. Am J Epidemiol (2004) 1.66
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation (2005) 1.66
Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol (2004) 1.63
Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci (2012) 1.63
CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered (2006) 1.62
Risk factors for mortality in the nurses' health study: a competing risks analysis. Am J Epidemiol (2010) 1.61
Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology (2011) 1.61
Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat (2011) 1.58
Lung cancer and vehicle exhaust in trucking industry workers. Environ Health Perspect (2008) 1.57
Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia. Arch Intern Med (2002) 1.57
Dietary fat and risk of postmenopausal breast cancer in a 20-year follow-up. Am J Epidemiol (2006) 1.55
Methods to evaluate risks for composite end points and their individual components. J Clin Epidemiol (2004) 1.54